19 research outputs found

    World Congress Integrative Medicine & Health 2017: part two

    No full text

    World Congress Integrative Medicine & Health 2017: part two

    No full text

    Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

    No full text
    International audienc
    corecore